Crypto Weekly: New year, same contagion Crypto Weekly: New year, same contagion Crypto Weekly: New year, same contagion

Crypto Weekly: New year, same contagion

Mads Eberhardt

Cryptocurrency Analyst

Summary:  The crypto market was troubled by contagion throughout much of 2022. It is safe to say that the market has so far extended this chaotic environment to 2023, as Genesis Trading has not yet reopened withdrawals for its lending division and Silvergate Bank incurred a loss of $718mn in Q4 and cut staff by 40% last week.

Gemini goes head-to-head with Digital Currency Group (DCG)

We are not two weeks into 2023, but it is safe to say that the crypto market has so far extended the chaotic environment of 2022 to 2023 considering that the contagion continues.

The ongoing contagion was obvious as early as January 2nd, at what time co-founder of crypto exchange Gemini, Cameron Winklevoss, posted an open letter on Twitter to the founder and CEO of Digital Currency Group (DCG) named Barry Silbert. DCG is the sole owner of institutional-focused trading firm Genesis Trading. Before November, Genesis was one of the largest crypto financial service providers on lending, market making, and prime brokerage. Following the loss of up to $1.2bn to bankrupt hedge fund Three Arrows Capital in May 2022 and $175mn stuck on FTX in November 2022, Genesis is at best facing a liquidity crisis but potentially insolvency.

This caused Genesis to halt withdrawals for its lending division in November. The halting of withdrawals includes more than $900mn originating from 340,000 clients of the Gemini Earn lending program facilitated by Genesis. Since Genesis halted withdrawals, these clients have not had access to their funds to great frustration to the clients and Gemini. Although it appears that merely Genesis is obligated to reimburse clients, the reputation of Gemini is at risk, so the firm is trying to seek a solution as soon as possible. Yet, according to Winklevoss, Genesis is not greatly interested in achieving a solution. In the open letter, Winklevoss accuses Silbert of “bad faith stall tactics” and states that “time is running out” for Genesis to return the $900mn to the clients of Gemini Earn. He ends the letter by saying that they seek a public commitment from Silbert to solve the problem by January 8th. Winklevoss does not state the consequence if not. There is currently no update.

Besides owning Genesis, DCG owns the largest crypto asset manager Grayscale, which has seen its funds trade at a steep discount of up to 60% of the underlying asset partly due to concerns over the financial health of the whole organization. Another reason is that Grayscale cannot redeem shares of its funds to keep them from trading at a discount to the underlying asset. So not only is the future unclear for Genesis, it is likewise unclear for the moneymaker of DCG namely Grayscale due to hefty management fees for its funds. We wrote about the uncertainties about Grayscale in our 2023 Crypto Outlook.

Silvergate Bank was not spared from the contagion

The contagion does not end with Genesis. On Thursday, US crypto bank Silvergate announced that it incurred a loss of $718mn by selling debt as it faced a liquidity crisis in the fourth quarter. In addition, the bank has cut its staff by 40% and written off its $182mn acquisition of Meta’s Diem project it carried out early last year. To make matters worse, Moody’s downgraded the bank’s ratings following its recent financials. Silvergate banks almost every major exchange and crypto institutional investor, so its significance for the ecosystem should not be underestimated. The stock is down by around 32% year to date.

Source: Saxo Group
Source: Saxo Group

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.